Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 94.
A
Abdel-Gadir, A;
Berber, R;
Porter, JB;
Quinn, PD;
Suri, D;
Kellman, P;
Hart, AJ;
... Skinner, JA; + view all
(2016)
Detection of metallic cobalt and chromium liver deposition following failed hip replacement using T2* and R2 magnetic resonance.
Journal of Cardiovascular Magnetic Resonance
, 18
, Article 29. 10.1186/s12968-016-0248-z.
|
 |
|
Abdel-Gadir, A;
Vorasettakarnkij, Y;
Ngamkasem, H;
Nordin, S;
Ako, EA;
Tumkosit, M;
Sucharitchan, P;
... Moon, JC; + view all
(2016)
Ultrafast Magnetic Resonance Imaging for Iron Quantification in Thalassemia Participants in the Developing World The TIC-TOC Study (Thailand and UK International Collaboration in Thalassaemia Optimising Ultrafast CMR).
Circulation
, 134
(5)
pp. 432-434.
10.1161/CIRCULATIONAHA.116.022803.
|
|
|
Ako, EOI;
Barber, N;
Kowalik, G;
Steeden, JA;
Porter, J;
Walker, J;
Muthurangu, V;
(2016)
MR-Augmented Cardiopulmonary Exercise Testing - a proof of concept in Sickle Cell Disease.
Presented at: Society for Cardiovascular Magnetic Resonance: 19th Annual SCMR Scientific Sessions, Los Angeles, California, USA.
|
|
|
Alzoubi, S;
Brody, L;
Rahman, S;
Mahul-Mellier, AL;
Mercado, N;
Ito, K;
El-Bahrawy, M;
... Hajji, N; + view all
(2016)
Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.
Oncotarget
, 7
(28)
pp. 44505-44521.
10.18632/oncotarget.9887.
|
|
|
Aneke, JC;
Huntley, N;
Porter, J;
Eleftheriou, P;
(2016)
Effect of automated red cell exchanges on oxygen saturation on-air, blood parameters and length of hospitalization in sickle cell disease patients with acute chest syndrome.
Nigerian Medical Journal
, 57
(3)
pp. 190-193.
10.4103/0300-1652.184073.
|
|
|
Anguita, E;
Gupta, R;
Olariu, V;
Valk, PJ;
Peterson, C;
Delwel, R;
Enver, T;
(2016)
A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.
Developmental Biology
, 411
(2)
pp. 277-286.
10.1016/j.ydbio.2016.02.002.
|
|
|
Anthias, CN;
(2016)
Related haematopoietic progenitor cell donor care: the influence of current guidance, and pathways to improvement.
Doctoral thesis , UCL (University College London).
|
|
|
Arachchillage, DRJ;
Mackie, IJ;
Efthymiou, M;
Chitolie, A;
Hunt, BJ;
Isenberg, DA;
Khamashta, M;
... Cohen, H; + view all
(2016)
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
Journal of Thrombosis and Haemostasis
, 14
(11)
pp. 2177-2186.
10.1111/jth.13475.
|
|
|
Aref, S;
Bailey, K;
Fielding, A;
(2016)
Measles to the Rescue: A Review of Oncolytic Measles Virus.
Viruses
, 8
(10)
10.3390/v8100294.
|
|
|
Arends, M;
Wanner, C;
Hughes, D;
Mehta, A;
Oder, D;
Watkinson, OT;
Elliott, PM;
... Hollak, CE; + view all
(2016)
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.
Journal of the American Society of Nephrology
, 28
(5)
pp. 1631-1641.
10.1681/ASN.2016090964.
|
|
B
|
Benson, AB;
Kiss, I;
Bridgewater, J;
Eskens, FALM;
Sasse, C;
Vossen, S;
Chen, J;
... Krivoshik, A; + view all
(2016)
BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer.
Clinical Cancer Research
, 22
(20)
pp. 5058-5067.
10.1158/1078-0432.CCR-15-3117.
|
|
Bentzen, AK;
Marquard, AM;
Lyngaa, R;
Saini, SK;
Ramskov, S;
Donia, M;
Such, L;
... Hadrup, SR; + view all
(2016)
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.
Nature Biotechnology
, 34
(10)
pp. 1037-1045.
10.1038/nbt.3662.
|
|
|
Bergerhoff, KF;
(2016)
Cellular and molecular events controlling acquisition of cytotoxic activity by melanoma-reactive CD4⁺ T cells in vivo.
Doctoral thesis , UCL (University College London).
|
|
Bochtler, W;
Gragert, L;
Patel, ZI;
Robinson, J;
Steiner, D;
Hofmann, JA;
Pingel, J;
... Mueller, CR; + view all
(2016)
A comparative reference study for the validation of HLA-matching algorithms in the search for allogeneic hematopoietic stem cell donors and cord blood units.
HLA
, 87
(6)
pp. 439-448.
10.1111/tan.12817.
|
|
|
Braso-Maristany, F;
Filosto, S;
Catchpole, S;
Marlow, R;
Quist, J;
Francesch-Domenech, E;
Plumb, DA;
... Tutt, AN; + view all
(2016)
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.
Nature Medicine
, 22
(11)
pp. 1303-1313.
10.1038/nm.4198.
|
|
|
Bridgewater, J;
Lopes, A;
Beare, S;
Duggan, M;
Lee, D;
Ricamara, M;
McEntee, D;
... Valle, JW; + view all
(2016)
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.
BMC Cancer
, 16
(1)
p. 153.
10.1186/s12885-016-2174-8.
|
|
|
Brimble, MA;
Zhou, J;
Morton, C;
Meagher, M;
Nathwani, AC;
Gray, JT;
Davidoff, AM;
(2016)
AAV Preparations Contain Contamination from DNA Sequences in Production Plasmids Directly Outside of the ITRs.
Presented at: 19th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), Washington DC, USA.
|
|
|
Brown, S;
Hinsley, S;
Ballesteros, M;
Bourne, S;
McGarry, P;
Sherratt, D;
Flanagan, L;
... Myeloma UK Clinical Trials Network, .; + view all
(2016)
The MUK five protocol: a phase II randomised, controlled, parallel group, multi-centre trial of carfilzomib, cyclophosphamide and dexamethasone (CCD) vs. cyclophosphamide, bortezomib (Velcade) and dexamethasone (CVD) for first relapse and primary refractory multiple myeloma.
BMC Hematology
, 16
, Article 14. 10.1186/s12878-016-0053-9.
|
C
|
Cappellini, MD;
Cassiman, D;
Marinakis, T;
Rosenbaum, H;
Bauduer, F;
Bjerrum, OW;
Fraga, C;
... Villarrubia, J; + view all
(2016)
Investigating rare haematological disorders - A celebration of 10 years of the Sherlock Holmes symposia.
European Oncology and Haematology
, 12
(1)
pp. 55-61.
10.17925/EOH.2016.12.01.55.
|
|
|
Caxaria, SMGL;
(2016)
Induced pluripotent stem cells (iPSCs) for research and therapy: induction of hepatic differentiation in iPSCs and evaluation of their quality as a model of in vivo development in the context of coagulation.
Doctoral thesis , UCL (University College London).
|
|
|
Chaganti, S;
Illidge, T;
Barrington, S;
Mckay, P;
Linton, K;
Cwynarski, K;
McMillan, A;
... British Committee for Standards in Haematology, British Committee for Standards in Haematology; + view all
(2016)
Guidelines for the management of diffuse large B-cell lymphoma.
Br J Haematol
, 174
(1)
pp. 43-56.
10.1111/bjh.14136.
|
|
|
Cohen, H;
Hunt, BJ;
Efthymiou, M;
Arachchillage, DR;
Mackie, IJ;
Clawson, S;
Sylvestre, Y;
... RAPS trial investigators, .; + view all
(2016)
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Lancet Haematology
, 3
(9)
e426-e436.
10.1016/S2352-3026(16)30079-5.
|
|
|
Cook, G;
Ashcroft, AJ;
Cairns, DA;
Williams, CD;
Brown, JM;
Cavenagh, JD;
Snowden, JA;
... National Cancer Research Institute Haemato-oncology Clinical Stu, .; + view all
(2016)
The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Lancet Haematology
, 3
(7)
e340-e351.
10.1016/S2352-3026(16)30049-7.
|
|
D
|
Dey, A;
(2016)
Enhancing the neutrophil-mediated anti-cancer response after oncolytic measles virus therapy in B cell malignancy: dissecting out the mechanism.
Doctoral thesis , UCL (University College London).
|
 |
E
|
El-Sharkawi, D;
(2016)
Studies to Investigate Epigenetic Factors in Acute Myeloid Leukaemia.
Doctoral thesis , UCL (University College London).
|
|
Engert, A;
Balduini, C;
Brand, A;
Coiffier, B;
Cordonnier, C;
Doehner, H;
de Wit, TD;
... Zieger, B; + view all
(2016)
The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Haematologica
, 101
(2)
pp. 115-208.
10.3324/haematol.2015.136739.
|
F
|
Furness, AJ;
Quezada, SA;
Peggs, KS;
(2016)
Neoantigen heterogeneity: a key driver of immune response and sensitivity to immune checkpoint blockade?
[Editorial comment].
Immunotherapy
, 8
(7)
pp. 763-766.
10.2217/imt-2016-0064.
|
G
|
Garbowski, MW;
Ma, Y;
Fucharoen, S;
Srichairatanakool, S;
Hider, R;
Porter, JB;
(2016)
Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay.
Translational Research
, 177
19-30.e5.
10.1016/j.trsl.2016.05.005.
|
|
|
Gardiner, C;
Kiyoko, K;
Patel, I;
Lane, P;
Machin, SJ;
Mackie, I;
(2016)
A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent.
Presented at: UNSPECIFIED.
|
|
|
Gardiner, C;
Lane, P;
Chitolie, A;
Nunn, M;
Kurono, H;
Machin, S;
Mackie, I;
(2016)
AUTOMATED ASSESSMENT OF THE COMPLEMENT SYSTEM.
Presented at: UNSPECIFIED.
|
|
Gardiner, C;
Patel, I;
Lane, P;
Kiyoko, K;
Machin, S;
Mackie, I;
(2016)
A NOVEL PROTHROMBIN TIME REAGENT THAT UTILISES TISSUE FACTOR GENERATED BY SILK-WORM-BACULOVIRUS TECHNOLOGY.
Presented at: UNSPECIFIED.
|
|
|
Genadieva-Stavrik, S;
Boumendil, A;
Dreger, P;
Peggs, K;
Briones, J;
Corradini, P;
Bacigalupo, A;
... Sureda, A; + view all
(2016)
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Annals of Oncology
, 27
(12)
pp. 2251-2257.
10.1093/annonc/mdw421.
|
|
Germain, DP;
Hughes, DA;
Nicholls, K;
Bichet, DG;
Giugliani, R;
Wilcox, WR;
Feliciani, C;
... Schiffmann, R; + view all
(2016)
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat.
New England Journal of Medicine
, 375
(6)
pp. 545-555.
10.1056/NEJMoa1510198.
|
|
|
Giugliani, R;
Niu, DM;
Ramaswami, U;
West, M;
Hughes, D;
Kampmann, C;
Pintos-Morell, G;
... Beck, M; + view all
(2016)
A 15-year perspective of the fabry outcome survey.
Journal of Inborn Errors of Metabolism and Screening
, 4
10.1177/2326409816666298.
|
|
|
Gleeson, M;
Hawkes, EA;
Cunningham, D;
Chadwick, N;
Counsell, N;
Lawrie, A;
Jack, A;
... Linch, D; + view all
(2016)
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial.
British Journal of Haematology
, 175
(4)
pp. 668-672.
10.1111/bjh.14287.
|
|
Goekbuget, N;
Dombret, H;
Ribera, J-M;
Fielding, AK;
Advani, A;
Bassan, R;
Chia, V;
... Kantarjian, H; + view all
(2016)
International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia.
Haematologica
, 101
(12)
pp. 1524-1533.
10.3324/haematol.2016.144311.
|
|
Goel, A;
Christudoss, P;
George, R;
Ramakrishna, B;
Amirtharaj, GJ;
Keshava, SN;
Ramachandran, A;
... Eapen, CE; + view all
(2016)
Arsenicosis, possibly from contaminated groundwater, associated with noncirrhotic intrahepatic portal hypertension.
Indian J Gastroenterol
, 35
(3)
pp. 207-215.
10.1007/s12664-016-0660-1.
|
|
Gökbuget, N;
Kelsh, M;
Chia, V;
Advani, A;
Bassan, R;
Dombret, H;
Doubek, M;
... Kantarjian, H; + view all
(2016)
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.
Blood Cancer J
, 6
(9)
, Article e473. 10.1038/bcj.2016.84.
|
|
|
Griffiths, PD;
Rothwell, E;
Raza, M;
Wilmore, S;
Doyle, T;
Harber, M;
O'Beirne, J;
... Emery, VC; + view all
(2016)
Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.
PLoS One
, 11
(9)
, Article e0163722. 10.1371/journal.pone.0163722.
|
|
Gu, Z;
Churchman, M;
Roberts, K;
Li, Y;
Liu, Y;
Harvey, RC;
McCastlain, K;
... Mullighan, CG; + view all
(2016)
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
Nature Communications
, 7
, Article 13331. 10.1038/ncomms13331.
|
|
H
|
Hachani, R;
Lowdell, M;
Birchall, M;
Hervault, A;
Mertz, D;
Begin-Colin, S;
Thanh, NT;
(2016)
Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents.
Nanoscale
, 8
(6)
pp. 3278-3287.
10.1039/c5nr03867g.
|
|
|
Hájek, R;
Masszi, T;
Petrucci, MT;
Palumbo, A;
Rosiñol, L;
Nagler, A;
Yong, KL;
... Ludwig, H; + view all
(2016)
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS).
Leukemia
, 31
(1)
pp. 107-114.
10.1038/leu.2016.176.
|
|
|
Heinrich, M;
Fisher, A;
Paton, B;
McCourt, O;
Beeken, RJ;
Hackshaw, A;
Wardle, J;
(2016)
Lifestyle in Multiple Myeloma - a longitudinal cohort study protocol.
BMC Cancer
, 16
, Article 387. 10.1186/s12885-016-2407-x.
|
|
|
Hendriksz, CJ;
Berger, KI;
Parini, R;
AlSayed, MD;
Raiman, J;
Giugliani, R;
Mitchell, JJ;
... Harmatz, PR; + view all
(2016)
Impact of long-term elosulfase alfa treatment on respiratory function in patients with Morquio A syndrome.
Journal of Inherited Metabolic Disease
, 39
(6)
pp. 839-847.
10.1007/s10545-016-9973-6.
|
|
|
Hendriksz, CJ;
Parini, R;
AlSayed, MD;
Raiman, J;
Giugliani, R;
Solano Villarreal, ML;
Mitchell, JJ;
... Harmatz, PR; + view all
(2016)
Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio A syndrome.
Molecular Genetics and Metabolism
, 119
(1-2)
pp. 131-143.
10.1016/j.ymgme.2016.05.018.
|
|
|
Holler, A;
Zech, M;
Ghorashian, S;
Pike, R;
Hotblack, A;
Velica, P;
Xue, S-A;
... Stauss, HJ; + view all
(2016)
Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy.
Haematologica
, 101
(4)
pp. 482-490.
10.3324/haematol.2015.132712.
|
|
|
Hotblack, A;
Seshadri, S;
Zhang, L;
Hamrang-Yousefi, S;
Chakraverty, R;
Escors, D;
Bennett, CL;
(2016)
Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.
Molecular Therapy
, 25
(2)
pp. 504-511.
10.1016/j.ymthe.2016.11.001.
|
|
Hughes, DA;
(2016)
Fabry disease: will markers of early disease enable early treatment and better outcomes?
Current Opinion in Cardiology
, 31
(4)
pp. 434-439.
10.1097/HCO.0000000000000308.
|
I
|
Ivey, A;
Hills, RK;
Simpson, MA;
Jovanovic, JV;
Gilkes, A;
Grech, A;
Patel, Y;
... Grimwade, D; + view all
(2016)
Assessment of Minimal Residual Disease in Standard-Risk AML.
The New England Journal Medicine
, 374
(5)
pp. 422-433.
10.1056/NEJMoa1507471.
|
K
|
Kumar, AJ;
Gimotty, PA;
Gelfand, J;
Buck, G;
Rowe, JM;
Goldstone, AH;
Fielding, A;
... Loren, AW; + view all
(2016)
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII.
American Journal of Hematology
, 91
(11)
pp. 1107-1112.
10.1002/ajh.24497.
|
|
L
|
Laethem, J-LV;
Riess, H;
Jassem, J;
Haas, M;
Martens, UM;
Weekes, C;
Peeters, M;
... Childs, BH; + view all
(2016)
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.
Targeted Oncology
, 12
(1)
pp. 97-109.
10.1007/s11523-016-0469-y.
|
|
|
Lidove, O;
Barbey, F;
Niu, DM;
Brand, E;
Nicholls, K;
Bizjajeva, S;
Hughes, DA;
(2016)
Fabry in the older patient: Clinical consequences and possibilities for treatment.
Molecular Genetics and Metabolism
, 118
(4)
pp. 319-325.
10.1016/j.ymgme.2016.05.009.
|
|
|
Lloyd, AJ;
Gallop, K;
Ali, S;
Hughes, D;
MacCulloch, A;
(2016)
Social preference weights for treatments in Fabry disease in the UK: a discrete choice experiment.
Current Medical Research and Opinion
, 33
(1)
pp. 23-29.
10.1080/03007995.2016.1232704.
|
|
M
|
Maciocia, N;
Wechalekar, A;
Yong, K;
(2016)
Monoclonal gammopathy of undetermined significance and smoldering myeloma (SMM): a practical guide to management.
Hematological Oncology
, 35
(4)
pp. 432-439.
10.1002/hon.2345.
|
|
|
Maciocia, PM;
Wawrzyniecka, P;
Philip, B;
Akarca, A;
Marafioti, T;
Pule, MA;
(2016)
Targeting the TCR beta-constant region for specific immunotherapy of T-cell malignancies.
Presented at: Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, ITALY.
|
|
|
Majumder, B;
Koganti, S;
Lowdell, MW;
Rakhit, RD;
(2016)
Intracoronary platelet and monocyte activation status within platelet-monocyte complexes are determinants of inflammation in ST elevation myocardial infarction1.
Clinical Hemorheology and Microcirculation
, 64
(1)
pp. 35-46.
10.3233/CH-162040.
|
|
|
Malhotra, K;
Butler, JS;
Yu, HM;
Selvadurai, S;
D'Sa, S;
Rabin, N;
Kyriakou, C;
... Molloy, S; + view all
(2016)
Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing.
BMC Cancer
, 16
, Article 444. 10.1186/s12885-016-2495-7.
|
|
|
Maybury, B;
Cook, G;
Pratt, G;
Yong, K;
Ramasamy, K;
(2016)
Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in Myeloma.
Biology of Blood and Marrow Transplantation
, 22
(11)
pp. 1926-1937.
10.1016/j.bbmt.2016.06.004.
|
|
|
McCourt, O;
Heinrich, M;
Fisher, A;
Paton, B;
Beeken, R;
Hackshaw, A;
Rismani, A;
... Yong, K; + view all
(2016)
Use of an 'adapted Zelen' design in a randomised controlled trial of a physiotherapist-led exercise intervention in patients with myeloma.
Presented at: th European Congress of the European Region of the World Confederation of Physical Therapy (ER-WCPT), Liverpool, UK.
|
|
Menezes, S;
Melandri, D;
Anselmi, G;
Perchet, T;
Loschko, J;
Dubrot, J;
Patel, R;
... Guermonprez, P; + view all
(2016)
The Heterogeneity of Ly6C(hi) Monocytes Controls Their Differentiation into iNOS(+) Macrophages or Monocyte-Derived Dendritic Cells.
Immunity
, 45
(6)
pp. 1205-1218.
10.1016/j.immuni.2016.12.001.
|
 |
|
Menger, L;
Sledzinska, A;
Bergerhoff, K;
Vargas, FA;
Smith, J;
Poirot, L;
Pule, M;
... Quezada, SA; + view all
(2016)
TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors.
Cancer Research
, 76
(8)
pp. 2087-2093.
10.1158/0008-5472.CAN-15-3352.
|
|
|
Mock, U;
Nickolay, L;
Philip, B;
Cheung, GW;
Zhan, H;
Johnston, IC;
Kaiser, AD;
... Qasim, W; + view all
(2016)
Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigy.
Cytotherapy
, 18
(8)
pp. 1002-1011.
10.1016/j.jcyt.2016.05.009.
|
N
|
Nathwani, AC;
Down, JF;
Goldstone, J;
Yassin, J;
Dargan, PI;
Virchis, A;
Gent, N;
... Harrison, JD; + view all
(2016)
Polonium-210 poisoning: a first-hand account.
The Lancet
, 388
(10049)
pp. 1075-1080.
10.1016/S0140-6736(16)00144-6.
|
|
|
Nordin, S;
Kozor, R;
Bulluck, H;
Castelletti, S;
Rosmini, S;
Abdel-Gadir, A;
Baig, S;
... Moon, JC; + view all
(2016)
Cardiac Fabry Disease With Late Gadolinium Enhancement Is a Chronic Inflammatory Cardiomyopathy.
[Letter].
Journal of the American College of Cardiology
, 68
(15)
pp. 1707-1708.
10.1016/j.jacc.2016.07.741.
|
|
O
|
O'Neill, AT;
Hockey, J;
O'Brien, P;
Williams, A;
Morris, TP;
Khan, T;
Hardwick, E;
(2016)
Knowledge of pelvic floor problems: a study of third trimester, primiparous women.
International Urogynecology Journal
, 28
(1)
pp. 125-129.
10.1007/s00192-016-3087-4.
|
|
Ohs, I;
van den Broek, M;
Nussbaum, K;
Munz, C;
Arnold, SJ;
Quezada, SA;
Tugues, S;
(2016)
Interleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis.
Nature Communications
, 7
, Article 13708. 10.1038/ncomms13708.
|
|
P
|
Patel, B;
Kirkwood, AA;
Dey, A;
Marks, DI;
McMillan, AK;
Menne, TF;
Micklewright, L;
... Fielding, AK; + view all
(2016)
Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial.
Leukemia
10.1038/leu.2016.219.
|
|
Pillinger, G;
Loughran, NV;
Piddock, RE;
Shafat, MS;
Zaitseva, L;
Abdul-Aziz, A;
Lawes, MJ;
... Rushworth, SA; + view all
(2016)
Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.
Oncotarget
, 7
(26)
pp. 39784-39795.
10.18632/oncotarget.9289.
|
|
|
Popat, R;
Brown, SR;
Flanagan, L;
Hall, A;
Gregory, W;
Kishore, B;
Streetly, M;
... Myeloma UK Early Phase Clinical Trial Network, .; + view all
(2016)
Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial.
The Lancet Haematology
, 3
(12)
e572-e580.
10.1016/S2352-3026(16)30165-X.
|
|
|
Pourcet, B;
Gage, MC;
León, TE;
Waddington, KE;
Pello, OM;
Steffensen, KR;
Castrillo, A;
... Pineda-Torra, I; + view all
(2016)
The nuclear receptor LXR modulates interleukin-18 levels in macrophages through multiple mechanisms.
Scientific Reports
, 6
, Article 25481. 10.1038/srep25481.
|
|
|
Prasanna, KS;
Goel, A;
Amirtharaj, GJ;
Ramachandran, A;
Balasubramanian, KA;
Mackie, I;
Zachariah, U;
... Eapen, CE; + view all
(2016)
Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure.
Indian Journal of Gastroenterology
, 35
(6)
pp. 432-440.
10.1007/s12664-016-0708-2.
|
|
Pugh, G;
Gravestock, HL;
Hough, RE;
King, WM;
Wardle, J;
Fisher, A;
(2016)
Health Behavior Change Interventions for Teenage and Young Adult Cancer Survivors: A Systematic Review.
Journal of Adolescent and Young Adult Oncology
, 5
(2)
pp. 91-105.
10.1089/jayao.2015.0042.
|
|
Pugh, SA;
Bowers, M;
Ball, A;
Falk, S;
Finch-Jones, M;
Valle, JW;
O'Reilly, DA;
... Primrose, JN; + view all
(2016)
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.
British Journal of Cancer
, 115
(4)
pp. 420-424.
10.1038/bjc.2016.208.
|
|
Q
|
Quek, L;
Otto, GW;
Garnett, C;
Lhermitte, L;
Karamitros, D;
Stoilova, B;
Lau, I-J;
... Vyas, P; + view all
(2016)
Genetically distinct leukemic stem cells in human CD34(-) acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.
Journal of Experimental Medicine
, 213
(8)
pp. 1513-1535.
10.1084/jem.20151775.
|
R
|
Raab, MS;
Cavo, M;
Delforge, M;
Driessen, C;
Fink, L;
Flinois, A;
Gonzalez-McQuire, S;
... Yong, K; + view all
(2016)
Multiple myeloma: practice patterns across Europe.
British Journal of Haematology
, 175
(1)
pp. 66-76.
10.1111/bjh.14193.
|
|
|
Reading, JL;
Quezada, SA;
(2016)
Too Much of a Good Thing? Chronic IFN Fuels Resistance to Cancer Immunotherapy.
Immunity
, 45
(6)
pp. 1181-1183.
10.1016/j.immuni.2016.12.004.
|
|
Reyal, Y;
Kayani, I;
Bloor, AJC;
Fox, CP;
Chakraverty, R;
Sjursen, A-M;
Fielding, AK;
... Peggs, KS; + view all
(2016)
Impact of Pretransplantation F-18-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma.
Biology of Blood and Marrow Transplantation
, 22
(7)
pp. 1234-1241.
10.1016/j.bbmt.2016.03.034.
|
|
Roddie, C;
(2016)
Targeting interference of CTLA-4 co-inhibition to tumour specific T cells to enhance activity and reduce toxicity.
Doctoral thesis , UCL (University College London).
|
|
Rohman, PJ;
Scott, E;
Richfield, L;
Ramaswami, U;
Hughes, DA;
(2016)
Pregnancies and associated events in women receiving Enzyme Replacement Therapy for late onset Glycogen Storage Disease Type II (Pompe disease).
Journal of Obstetrics and Gynaecology Research
, 42
(10)
pp. 1263-1271.
10.1111/jog.13055.
|
S
|
Santos e Sousa, P;
Ward, S;
Lomas, C;
Conlan, T;
Shorrock, H;
Means, TK;
Plagnol, V;
... Bennett, CL; + view all
(2016)
A systems immunology approach to GVHD defines skin-autonomous control of donor T cells.
Presented at: 2016 Keystone Symposia Conference: Immunity in Skin Development, Homeostasis and Disease, 28 February - 2 March 2016, Tahoe City, California, USA, Granlibakken, CA.
|
|
|
Sellar, RS;
Fraser, L;
Khwaja, A;
Gale, RE;
Marafioti, T;
Akarca, A;
Hubank, M;
... Linch, DC; + view all
(2016)
Cell cycle status in AML blast cells from peripheral blood, bone marrow aspirates and trephines and implications for biological studies and treatment.
British Journal of Haematology
, 174
(2)
pp. 275-279.
10.1111/bjh.14055.
|
|
Sharief, LAT;
Lawrie, AS;
Mackie, IJ;
Halimeh, S;
Kappert, G;
Smith, C;
Peyvandi, F;
(2016)
Plasma factor XIII level variations during menstrual cycle.
Blood Coagulation & Fibrinolysis
, 27
(7)
pp. 786-790.
10.1097/MBC.0000000000000491.
|
|
Sivakumaran, S;
Henderson, S;
Ward, S;
Santos E Sousa, P;
Manzo, T;
Zhang, L;
Conlan, T;
... Bennett, CL; + view all
(2016)
Depletion of CD11c(+) cells in the CD11c.DTR model drives expansion of unique CD64(+) Ly6C(+) monocytes that are poised to release TNF-α.
European Journal of Immunology
, 46
(1)
pp. 192-203.
10.1002/eji.201545789.
|
|
|
Smith, D;
Yong, K;
(2016)
Advances in understanding prognosis in myeloma.
British Journal of Haematology
, 175
(3)
pp. 367-380.
10.1111/bjh.14304.
|
|
Stavrou, M;
(2016)
CAR Gene Transfer to Generate Antigen Specific Regulators.
Doctoral thesis , UCL (University College London).
|
T
|
Taher, AT;
Porter, JB;
Kattamis, A;
Viprakasit, V;
Cappellini, MD;
(2016)
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes.
Drug Design, Development and Therapy
, 10
pp. 4073-4078.
10.2147/DDDT.S117080.
|
|
|
Taieb, J;
Balogoun, R;
Le Malicot, K;
Tabernero, J;
Mini, E;
Folprecht, G;
Van Laethem, JL;
... PETACC8 investigators, .; + view all
(2016)
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.
Annals of Oncology
10.1093/annonc/mdw687.
(In press).
|
|
Thomas, MR;
(2016)
The role of antibodies in acquired thrombotic thrombocytopenic purpura.
Doctoral thesis , UCL (University College London).
|
|
|
Thomas, S;
Straathof, K;
Himoudi, N;
Anderson, J;
Pule, M;
(2016)
An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers.
PLoS One
, 11
(3)
, Article e0152196. 10.1371/journal.pone.0152196.
|
|
|
Tummala, H;
Walne, AJ;
Williams, M;
Bockett, N;
Collopy, L;
Cardoso, S;
Ellison, A;
... Vulliamy, T; + view all
(2016)
DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit Maturation.
American Journal of Human Genetics
, 99
(1)
pp. 115-124.
10.1016/j.ajhg.2016.05.002.
|
|
U
|
Underwood, M;
Peyvandi, F;
Garagiola, I;
Machin, S;
Mackie, I;
(2016)
Degradation of two novel congenital TTP ADAMTS13 mutants by the cell proteasome prevents ADAMTS13 secretion.
Thrombosis Research
, 147
pp. 16-23.
10.1016/j.thromres.2016.09.014.
|
Y
|
Yong, K;
Cavet, J;
Johnson, P;
Morgan, G;
Williams, C;
Nakashima, D;
Akinaga, S;
... Cavenagh, J; + view all
(2016)
Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignancies.
British Journal of Cancer
, 114
(1)
pp. 7-13.
10.1038/bjc.2015.422.
|
|
Yong, K;
Delforge, M;
Driessen, C;
Fink, L;
Flinois, A;
Gonzalez-McQuire, S;
Karlin, L;
... Cavo, M; + view all
(2016)
Multiple myeloma: patient outcomes in real-world practice.
British Journal of Haematology
, 175
(2)
pp. 252-264.
10.1111/bjh.14213.
|
|
|
Yuan, Z;
Lourenco, SDS;
Sage, EK;
Kolluri, KK;
Lowdell, MW;
Janes, SM;
(2016)
Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy.
Cytotherapy
, 18
(7)
pp. 860-869.
10.1016/j.jcyt.2016.04.005.
|
|
